Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal study.

Autor: Huntington SF; Yale School of Medicine, New Haven, CT, USA., Cheng WY; Analysis Group, Inc, Boston, MA, USA., Sarpong EM; Merck & Co., Inc, Rahway, NJ, USA., Leng S; Merck & Co., Inc, Rahway, NJ, USA., Farooqui MZH; Merck & Co., Inc, Rahway, NJ, USA., Agu US; University of Arizona, Tucson, AZ, USA., Catillon M; Analysis Group, Inc, Boston, MA, USA., Lejeune D; Groupe d'analyse, Ltée, Montréal, QC, Canada., Downes N; Analysis Group, Inc, Boston, MA, USA., Matay L; Analysis Group, Inc, Boston, MA, USA., Duh MS; Analysis Group, Inc, Boston, MA, USA., De Nigris E; MSD (UK) Limited, London, UK.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2024 Jul; Vol. 65 (7), pp. 932-942. Date of Electronic Publication: 2024 May 02.